Equity Profile
Pre-Earnings Brief
Waters Corp (WAT) operates in the health care sector, specifically in life sciences tools and services. The company is known for its analytical instruments and software that help researchers and scientists in drug development and quality control, making it a key player in the health care and pharmaceutical industries.
EPS
Earnings per share is a crucial indicator of the company's profitability and performance this quarter.
Revenue
Revenue figures provide insight into the company's sales performance and market demand for its products.
Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
8Q
EPS Beat Rate
100%
Avg EPS Surprise
+3.56%
Avg Stock Reaction
+0.84%
In Q4-2025, Waters Corp reported an EPS of $4.53, slightly beating expectations. However, the stock fell by nearly 14% the following day, indicating market concerns despite the earnings beat.
Management Promises & Guidance
Analysts expect Waters Corp to report an EPS of $2.31 and revenue of $1.2 billion for Q1-2026. The market is keenly observing how the company will navigate potential challenges in the life sciences sector.
Bull Case
If Waters exceeds EPS expectations and demonstrates strong revenue growth, it could signal robust demand for its products, leading to a positive market reaction.
Bear Case
Conversely, if the company misses earnings expectations or provides weak guidance, it could raise concerns about its growth trajectory and lead to a significant sell-off.
EPS
$2.31Earnings per share is a crucial indicator of the company's profitability and performance this quarter.
Revenue
$1.2BRevenue figures provide insight into the company's sales performance and market demand for its products.
Expectations
The print will turn on these two things.
Q1
Will the EPS exceed $2.31, and if so, by how much?
A strong EPS performance could indicate better-than-expected demand and operational efficiency, influencing investor sentiment.
Q2
What are the revenue growth prospects for the upcoming quarters?
Investors will be looking for guidance on future revenue to assess the company's growth trajectory and market position.
Edge
Why consensus could be wrong
The Street may be underestimating the potential for Waters to exceed EPS expectations due to strong demand in the life sciences sector, which could lead to a significant upside.
Supporting Evidence
Waters has consistently beaten EPS estimates in the past, indicating strong operational performance.
The options market is pricing in a move of 6.53%, suggesting traders expect volatility that could favor a positive outcome.
Key Risk
If the company reports an EPS below $2.27, it could challenge the current positive sentiment.
Edge
Pre-commit to what would confirm each case.
The market is debating whether Waters Corp can sustain its growth in a competitive environment, making these thresholds critical.
Bull Confirmed If
An EPS of $2.35 or higher would confirm strong operational performance and market demand.
Bear Confirmed If
An EPS below $2.27 would raise concerns about the company's growth and profitability.
Pre-Earnings Positioning
Implied Move
±6.53%
Historical Avg
±6.8%
The options market is pricing in a move of about 6.53%, suggesting that traders expect some volatility around the earnings announcement.
Options are pricing ±6.5% while WAT has averaged ±6.8% over the last 8 prints — setup is roughly in line with history.
30d HV
32.8%
Edge
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
n=30Fade rate: 7 of 20 (35%)
This setup has occurred 30 times across Health Care in the last 2 years. 13 of 20 (65%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 5.8%, with a raw directional average of +2.2% (modestly positive historical bias).
Preparation
Likely market behavior by outcome — not investment advice.
Beat & Raise
If Waters beats expectations, history suggests a potential average move of +0.84%, confirming strong demand and operational efficiency.
In-Line / Cautious
If results are in line with expectations, the stock may see muted movement as investors await further guidance.
Miss
A miss could lead to a decline, with historical patterns suggesting an average drop of around -2.69%.
Preparation
House & Senate STOCK Act disclosures over the trailing 6 months.
Trades
6
2 buys·2 sells
Members
5
House only
Est. Notional
$6,006.00–$90,000.00
disclosed dollar ranges
Most Active Members
2 trades
Net selling
1 trade
Net buying
1 trade
Net buying
0 trades
Mixed
Recent Transactions
Traded Mar 18, 2026 · disclosed Apr 7, 2026
$1,001.00–$15,000.00
Traded Mar 10, 2026 · disclosed Apr 13, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.
Preparation
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
LOEWS CORP
Traded Feb 13, 2026 · disclosed Mar 18, 2026
$1,001.00–$15,000.00
Traded Feb 10, 2026 · disclosed Feb 23, 2026
$1,001.00–$15,000.00
Traded Feb 9, 2026 · disclosed Mar 6, 2026
$1,001.00–$15,000.00